Share on :

Asset Summary

Daily Performance Report for LABD ETF: Nov 7, 2024

Summary: The day started with LABD ETF opening at $5.23 and closing at $5.25. The ETF showed resilience throughout the day, with the highest price observed at $5.25 and the lowest at $5.23. The underlying asset had a trading range of $0.02 Overall, it was a positive trading day for LABD ETF, reflecting investor optimism and market activity.

Change in Closing Price: There was a net increase of $0.02 or 0.38% in the closing price from the opening to the closing price over the day.

Volume Analysis: Trading volume for LABD ETF was 6,545 units during Nov 7, 2024, indicating active market participation and investor interest.

Opening Price: The day started at $5.23.

Highest Price: The highest price observed during the day was $5.25.

Lowest Price: The lowest price observed during the day was $5.23.

Closing Price: The day ended at $5.25.

Asset Performance Metrics and Risk Characteristics:

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. By using various technical indicators and chart patterns, investors can gain insights into market trends, price momentum, and potential turning points. This section delves into essential technical metrics, including moving averages, pivot points, and other indicators that provide a snapshot of an asset's current technical stance. Analyzing these indicators helps investors identify entry and exit points, assess market sentiment, and refine their trading strategies. Explore the following technical analysis data to understand the asset's performance dynamics and make better-informed decisions.

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Maximize Your LABD Trading Now

Revolutionize your investment in LABD with Rank My Trade’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Elevate your trading approach instantly with Rank My Trade now and achieve better trading outcomes!

Start Optimizing Now

Frequently Asked Questions

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.

LABD rebalances its holdings daily to maintain its -3x leverage ratio relative to the S&P Biotechnology Select Industry Index. This daily rebalancing ensures that the ETF remains aligned with its -3x daily performance target, though it can result in performance deviations over longer periods due to compounding effects.

Historical performance data for LABD includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand LABD's track record in achieving its leveraged inverse objective.

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.

LABD aims to deliver three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. Over time, due to the effects of compounding and daily rebalancing, its performance may differ significantly from the index.

LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.

Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.

Investors can buy shares of LABD through a brokerage account. The ETF is traded on major stock exchanges under the ticker symbol "LABD" and can be bought and sold like other stocks and ETFs.

Optimize Your LABD Trading Now

Revolutionize your investment in LABD with Rank My Trade’s innovative trading solutions. Benefit from our comprehensive risk management features and sophisticated price analysis tools. Start optimizing your trades today with Rank My Trade now and achieve better trading outcomes!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. RankMyTrade (RMT) has not independently verified this data and does not guarantee its accuracy. The information and calculations provided by RankMyTrade are for educational and informational purposes only and should not be construed as financial or investment advice.

With any investment, your capital is at risk. The value of your portfolio go down as well as up. Past performance is no guarantee of future results. By using this website, you accept our Terms of Service, Privacy Policy, and Payment Agreement.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind. Unless otherwise noted, RankMyTrade and its affiliates are not partners, affiliates, or licensees of these companies.

Supported Assets & ETFs